Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis

Marija Geroldinger-Simić, Shaghayegh Bayati, Emmie Pohjanen, Norbert Sepp, Peter Nilsson, Elisa Pin

Open source

DOI
10.3390/ijms24065629
Published
2023-03-15
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms24065629,
  title = {Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis},
  author = {Marija Geroldinger-Simić and Shaghayegh Bayati and Emmie Pohjanen and Norbert Sepp and Peter Nilsson and Elisa Pin},
  year = {2023},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms24065629},
  url = {https://doi.org/10.3390/ijms24065629}
}

RIS

TY  - JOUR
TI  - Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis
AU  - Marija Geroldinger-Simić
AU  - Shaghayegh Bayati
AU  - Emmie Pohjanen
AU  - Norbert Sepp
AU  - Peter Nilsson
AU  - Elisa Pin
PY  - 2023
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms24065629
UR  - https://doi.org/10.3390/ijms24065629
ER  - 

APA

Geroldinger-Simić, M., Bayati, S., Pohjanen, E., Sepp, N., Nilsson, P., & Pin, E. (2023). Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065629

Source records